Background & Aims: Metabolic syndrome and its associated morbidities have become a
major public health problem in both developed and developing countries. Insulin resistance …

AIM: To evaluate the association of metabolic syndrome (MS) and colorectal cancer and
adenomas in a Western country, where the incidence of MS is over 27%. METHODS: This …

Background: There has been constant speculation about the association between metabolic
syndrome (MetS) and colorectal neoplasia (CN); however, the published results are …

Background Metabolic syndrome was linked with various chronic diseases, including
cancer. The study on the effect of metabolic syndrome on colorectal cancer (CRC) was not …

Background: Metabolic syndrome (MetS) has been associated with colorectal adenomas
and cancer. However, MetS definitions have changed over time, leading to a heterogeneity …

Abstract Background Metabolic syndrome (MetS) is composed of cardiovascular risk factors
including insulin resistance, obesity, dyslipidemia, and hypertension. Most of the …

Background Metabolic syndrome (MetS) has been identified as a contributor to cancer
development. However, reports concerning the association between MetS and colorectal …

Abstract Background and Aims: Epidemiologic studies provide evidence for a link between
obesity or diabetes and the risk for colorectal cancer. However, there is a lack of information …

BACKGROUND The authors tested the hypothesis that the metabolic syndrome (≥ 3 of the
following components: high blood pressure, increased waist circumference …

AIM OF THE STUDY: We assessed the relation between metabolic syndrome (MetS) and its
components and colorectal cancer. METHODS: We analysed data from a multicentre case …